161 related articles for article (PubMed ID: 28199006)
1. Symptom incidence, distress, cancer-related distress, and adherence to chemotherapy among African American women with breast cancer.
Yee MK; Sereika SM; Bender CM; Brufsky AM; Connolly MC; Rosenzweig MQ
Cancer; 2017 Jun; 123(11):2061-2069. PubMed ID: 28199006
[TBL] [Abstract][Full Text] [Related]
2. Protocol for Symptom Experience, Management, Outcomes, and Adherence in Women Receiving Breast Cancer Chemotherapy.
Nugent BD; McCall MK; Connolly M; Mazanec SR; Sereika SM; Bender CM; Rosenzweig MQ
Nurs Res; 2020; 69(5):404-411. PubMed ID: 32520763
[TBL] [Abstract][Full Text] [Related]
3. Differences in Coping Among African American Women With Breast Cancer and Triple-Negative Breast Cancer.
Watkins CC; Kamara Kanu I; Hamilton JB; Kozachik SL; Gaston-Johansson F
Oncol Nurs Forum; 2017 Nov; 44(6):689-702. PubMed ID: 29052667
[TBL] [Abstract][Full Text] [Related]
4. The relationships among coping strategies, religious coping, and spirituality in African American women with breast cancer receiving chemotherapy.
Gaston-Johansson F; Haisfield-Wolfe ME; Reddick B; Goldstein N; Lawal TA
Oncol Nurs Forum; 2013 Mar; 40(2):120-31. PubMed ID: 23448737
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Adherence and Treatment Delays among African American Women Recommended to Receive Breast Cancer Chemotherapy.
Gallups SF; Connolly MC; Bender CM; Rosenzweig MQ
Womens Health Issues; 2018; 28(6):553-558. PubMed ID: 30241793
[TBL] [Abstract][Full Text] [Related]
6. The attitudes, communication, treatment, and support intervention to reduce breast cancer treatment disparity.
Rosenzweig M; Brufsky A; Rastogi P; Puhalla S; Simon J; Underwood S
Oncol Nurs Forum; 2011 Jan; 38(1):85-9. PubMed ID: 21186164
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy.
Hu X; Chehal PK; Kaplan C; Krukowski RA; Lan RH; Stepanski E; Schwartzberg L; Vidal G; Graetz I
JAMA Netw Open; 2021 Jun; 4(6):e2112076. PubMed ID: 34061200
[TBL] [Abstract][Full Text] [Related]
8. Understanding sleep disturbances in African-American breast cancer survivors: a pilot study.
Taylor TR; Huntley ED; Makambi K; Sween J; Adams-Campbell LL; Frederick W; Mellman TA
Psychooncology; 2012 Aug; 21(8):896-902. PubMed ID: 21648016
[TBL] [Abstract][Full Text] [Related]
9. Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer.
Hu X; Walker MS; Stepanski E; Kaplan CM; Martin MY; Vidal GA; Schwartzberg LS; Graetz I
JAMA Netw Open; 2022 Aug; 5(8):e2225485. PubMed ID: 35947386
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with symptom distress in women with breast cancer prior to initiation of chemotherapy.
Mazanec SR; Park S; Connolly MC; Rosenzweig MQ
Appl Nurs Res; 2021 Dec; 62():151515. PubMed ID: 34815009
[TBL] [Abstract][Full Text] [Related]
11. Previous chemotherapy influences the symptom experience and quality of life of women with breast cancer prior to radiation therapy.
Hofsø K; Miaskowski C; Bjordal K; Cooper BA; Rustøen T
Cancer Nurs; 2012; 35(3):167-77. PubMed ID: 21760482
[TBL] [Abstract][Full Text] [Related]
12. Measurement of symptom distress in women with early-stage breast cancer.
Boehmke MM
Cancer Nurs; 2004; 27(2):144-52. PubMed ID: 15253172
[TBL] [Abstract][Full Text] [Related]
13. Adherence to intravenous chemotherapy in African American and white women with early-stage breast cancer.
Wells JS; Strickland OL; Dalton JA; Freeman S
Cancer Nurs; 2015; 38(2):89-98. PubMed ID: 24831041
[TBL] [Abstract][Full Text] [Related]
14. Predictors of symptom distress in women with breast cancer during the first chemotherapy cycle.
Boehmke MM; Brown JK
Can Oncol Nurs J; 2005; 15(4):215-27. PubMed ID: 16405206
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of physical problems detected by the distress thermometer and problem list in patients with breast cancer.
McFarland DC; Shaffer KM; Tiersten A; Holland J
Psychooncology; 2018 May; 27(5):1394-1403. PubMed ID: 29315955
[TBL] [Abstract][Full Text] [Related]
16. Quality of sleep and related factors during chemotherapy in patients with stage I/II breast cancer.
Kuo HH; Chiu MJ; Liao WC; Hwang SL
J Formos Med Assoc; 2006 Jan; 105(1):64-9. PubMed ID: 16440072
[TBL] [Abstract][Full Text] [Related]
17. Beliefs in Chemotherapy and Knowledge of Cancer and Treatment Among African American Women With Newly Diagnosed Breast Cancer.
Jiang Y; Sereika SM; Bender CM; Brufsky AM; Rosenzweig MQ
Oncol Nurs Forum; 2016 Mar; 43(2):180-9. PubMed ID: 26906129
[TBL] [Abstract][Full Text] [Related]
18. Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities.
Boehmke MM; Dickerson SS
Cancer Nurs; 2005; 28(5):382-9. PubMed ID: 16192830
[TBL] [Abstract][Full Text] [Related]
19. Patterns of symptom distress in older women after surgical treatment for breast cancer.
Kenefick AL
Oncol Nurs Forum; 2006 Nov; 33(2):327-35. PubMed ID: 16518448
[TBL] [Abstract][Full Text] [Related]
20. Virtual reality as a distraction intervention for women receiving chemotherapy.
Schneider SM; Prince-Paul M; Allen MJ; Silverman P; Talaba D
Oncol Nurs Forum; 2004; 31(1):81-8. PubMed ID: 14722591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
